Stocks in News Today

Tata Metaliks

[{"selector":"#anim-9075e167-796e-457e-816f-7bb6c4f72c9a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f178398a-4d9e-4741-b3f1-096a975d451c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5c8c22ba-d473-4ed6-aa65-daa4a5ffd28f","keyframes":{"transform":["translate3d(0px, -698.10334%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-785d9a65-f7fc-4a32-9c29-38f1662cac17","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2e28b1cb-b0b6-4be5-b0b3-6fe982b695a8","keyframes":{"transform":["translate3d(0px, -211.68979%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] • Q3 net profit down 73.4% YoY at Rs 9.5 cr • Revenue up 14.6% YoY at Rs 790.2 cr • EBITDA down 42.9% YoY at Rs 38.7 cr • Margin at 4.9% vs 9.8% YoY Check Share Price

Glenmark Pharmaceuticals

[{"selector":"#anim-23757b62-19bf-471d-9952-9daacc2acc2c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b30eeee4-aec6-443c-b386-aa1d85c576db","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-df84137f-a55c-45c4-a421-43e4d4414211","keyframes":{"transform":["translate3d(0px, -386.85635%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a6a49e4d-ef01-4977-813d-a4a25adbef38","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-42aa1021-f926-44ef-b0d9-4d14f98fe572","keyframes":{"transform":["translate3d(0px, -211.68979%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Glenmark Pharmaceuticals will divest select brands from its dermatology segment, for India and Nepal territories, to Eris Oaknet Healthcare for Rs.340 cr. Check Share Price

Eris Lifesciences

[{"selector":"#anim-c83268a5-8d2b-4be1-9552-d1c9a63ad411","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d874747b-47e8-41dd-a5dd-75f9039858f5","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8957cb33-d3da-4d35-a05e-9bca17922531","keyframes":{"transform":["translate3d(0px, -698.10334%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ff157609-b46d-4ae2-bb99-7d3b81b1351f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e2edd492-fc63-427f-8882-9781429c1cb4","keyframes":{"transform":["translate3d(0px, -211.68979%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] • Q3 net profit up 1.1% YoY at Rs 101.8 cr • Revenue up 27.4% YoY at Rs 423.2 cr • EBITDA up 12.7% YoY at Rs 137.1 cr • Margin at 32.4% vs 36.6% YoY Check Share Price

Arrow Check More Details Swipe Up More Details

Check out more 5paisa webstories Swipe Up More Webstories